Phar­ma com­pa­nies in the meta­verse? Maybe not yet, but time to start think­ing fu­ture use, ex­perts say

Thanks to Face­book’s name change to Meta last year, every­one is talk­ing about the meta­verse — es­pe­cial­ly com­pa­nies and brands scram­bling to fig­ure out how they’re go­ing to play on the plat­form. But should phar­ma com­pa­nies be jump­ing in to the meta­verse, what­ev­er it is?

Yes and no, in­dus­try ex­perts say. There are some ini­tial plays for phar­ma, like us­ing aug­ment­ed or vir­tu­al re­al­i­ty to bet­ter show how a drug works or what Parkin­son’s dis­ease tremors feel like. The fu­ture of the meta­verse is still very much in the fu­ture, along with its ma­jor us­es across bio­phar­ma in R&D, pa­tient com­mu­ni­ca­tions, drug launch­es, man­u­fac­tur­ing and mar­ket­ing. But it is on the way.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.